TACROLIMUS capsules (Advagraf®)

Clinical Indication

Immunosuppression

Comments

Modified-release

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.